An update from Cogstate Ltd ( (AU:CGS) ) is now available.
Cogstate Ltd has announced an update regarding its ongoing on-market buy-back of ordinary fully paid securities. As of April 29, 2025, the company has repurchased a total of 5,204,556 securities, including 138,939 securities bought back on the previous day. This buy-back initiative reflects Cogstate’s strategic efforts to manage its capital structure and potentially enhance shareholder value.
More about Cogstate Ltd
Cogstate Ltd operates in the healthcare industry, focusing on cognitive science and technology. The company provides cognitive assessment services and tools, primarily targeting clinical trials, academic research, and healthcare markets.
YTD Price Performance: 25.93%
Average Trading Volume: 10,507
Technical Sentiment Signal: Sell
Current Market Cap: $145.6M
See more insights into CGS stock on TipRanks’ Stock Analysis page.